Assisted Reproductive Technology (ART) Market Trends Drivers And Projections Rep

Posted by thomas on November 25th, 2020

Assisted reproductive technology (ART) is infertility treatment which involves laboratory fusion of ovule extracted from the women’s ovaries with the male sperms. Within the recent decades there has been a dramatic rise within the number of couples who are choosing to conceive after the age of 35. This progression started with rise of feminism and women stepping out of their solely domestic roles. Today, 15% of birth-giving people are 35 and older, up from 11% in 2002 and eight percent in 1990. With prevalent trend of delayed pregnancies across different parts of the planet and therefore the use of ovulation test kits is anticipated to grow significantly, thus stimulating the assisted reproductive technology (ART) market.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1402

Assisted Reproductive Technology (ART) Market Dynamics

Assisted reproductive technology (ART) are often wont to bypass fertility problems while conserving the genetic connection. 1.5 million assisted reproductive technology (ART) cycles were conducted worldwide in 2012. It should however be mentioned that nearly 76.7% of assisted reproductive technology (ART) procedures failed, and about 23.3% were successful. Generally, assisted reproductive technology (ART) is usually recommended when other methods haven't been successful and when there's various male infertility or tubal blocking.

Nearly 0.3% of all infants are born annually through assisted reproductive technology (ART) across the world . Growing awareness about assisted reproductive technology and diminished discomfort around pregnancy related disorders within the social scenario have contributed sufficient market boost of the assisted reproductive technology market. assisted reproductive technology (ART) statistics provided by the planet Fertility Patterns show that, Mexico's birth rate is around 2 kids per mother, well below the amount required to support the present population of Mexico. Same trend has been noticed in Brazil where the birth rate is additionally smaller, at 1.75. Costa Rica’s birth rate is right down to 1.66. These declining fertility rates can stimulate the expansion of assisted reproductive technology (ART).

A major limiting factor for the market is that the stringent rules and regulations. The transfer of several of embryos during a single cycle increases the probabilities of multiple births. Burdened by the increased social costs and health risks related to multiple births, legislation or guidelines from professional societies are introduced in many countries. Also, moderate success rate, is predicted to act as a restraining factor on the worldwide market within the years ahead.

Assisted Reproductive Technology (ART) Market: Regional Outlook

North America dominated the market in 2019 with a share of USD 9.13 billion. In the U.S., the amount of births dropped by over 2% over 2017-2018. Consistent with assisted reproductive technology (ART) statistics by Center of Disease Control and Prevention (CDC) within the U.S., over 284,385 assisted reproductive technology (ART) cycles were performed in 2017 which resulted in over 68,000 live births. 87,535 cycles were performed for egg or embryo banking during which the intent was to freeze all resulting eggs or embryos for future assisted reproductive technology (ART) cycles. As more women choose late births, egg freezing is becoming more common. Though assisted reproductive technology (ART) remains relatively uncommon compared to its demand, its use has doubled over the past decade. Nearly 1.7% of all infants born within the U.S. annually are conceived through assisted reproductive technology (ART).

The Asia Pacific region is predicted to witness substantial growth as a result of an increased understanding of healthy lifestyles. However, the growing rate of medical tourism is fuelling demand for assisted reproductive technology (ART), which successively was expected to assist regional market growth.

The market in Europe as well as the rest of the world is predicted to witness opportunity for expansion as people in countries including the UAE, Brazil, South Africa , the UK, Germany, and France are delaying marriage and child birth and sometimes facing infertility.

Assisted Reproductive Technology (ART) Market: Key Players
• Merck KGaA (Germany)
• Cooper Surgical (Denmark)
• Fujifilm Irvine Scientific (US)
• Vitroife AB (Sweden)
• Thermo Fisher Scientific (US)
• Celmatix, Inc. (US)
• Anecova (Switzerland)
• OvaScience (US)
• Ferring Pharmaceuticals (US)
• FertiPro N.V. (Belgium)

The COVID-19 Impact on Assisted Reproductive Technology (ART) Market:

The recent outbreak of COVID-19 has impacted the expansion of the market as in several countries IVF or other assisted reproductive technology (ART) procedures are being postponed or cancelled. Many studies have noted that women trying to conceive via assisted reproductive technology (ART) are susceptible to infection owing to lower immunity. The restricted movements and shutdown of the ART facilities in developed also as developing nations has resulted into reduction of couples approaching ART. However, a plethora of gynecologists are maintaining the array of surrogate or couples enlisted under assisted reproductive technology (ART) procedures by using digital platform, hence after a brief span of decline in growth, the market is estimated to grow in later phase 2021.

To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/report-detail/assisted-reproductive-technology-art-market

Report Highlights:

• Detailed overview of the parent market
• Changing assisted reproductive technology (ART) market dynamics
• In-depth assisted reproductive technology (ART) market segmentation
• Historical, present, and projected assisted reproductive technology (ART) market size in terms of volume and value
• Recent assisted reproductive technology (ART) market trends and developments
• Competitive landscape
• Strategies of key players and products offered
• Segments, sub-segments, and geographical regions exhibiting promising growth
• A neutral perspective on assisted reproductive technology (ART) market performance

Assisted Reproductive Technology (ART) Market: Segmentation

For the purpose of this report, Reports and Data has segmented into the global assisted reproductive technology (ART) market on the basis of procedure, technology, type, end use and region:

Procedures Outlook (Revenue, USD Billion; 2017-2027)

• Fresh Donor
• Fresh Non-Donor
• Frozen Donor
• Frozen Non-Donor
• Embryo/Egg Banking

Technology Outlook (Revenue, USD Billion; 2017-2027)

• In-Vitro Fertilization (IVF)

o    IVF Using Intra-Cytoplasmic Sperm Injection (ICSI)

o    IVF Without Using Intra-Cytoplasmic Sperm Injection (ICSI)

• Pre-Implantation Genetic Screening (PGS)
• Frozen Embryo Replacement (FER)
• Others

Type Outlook (Revenue, USD Billion; 2017-2027)

• Artificial Insemination
• Surrogacy
• Ovulation Induction
• Others

End Use Outlook (Revenue, USD Billion; 2017-2027)

• Fertility Clinics
• Hospitals
• Clinical Research
• Others

Regional Outlook (Revenue, USD Billion; 2017-2027)

• North America

o    U.S

• Europe

o    U.K

o    France

• Asia Pacific

o    China

o    India

o    Japan

• MEA
• Latin America

o    Brazil